Effect of Oral Furosemide on patients with preeclampsia during pregnancy

Assessing the clinical effects of a short-term course of Oral Furosemide in postpartum period in patients with preeclampsia during pregnancy : A Randomized Controlled Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230722058884N1

Enrollment

118

Registered

2023-11-30

Start date

2023-09-23

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unspecified pre-eclampsia. Unspecified pre-eclampsia

Interventions

Intervention group: Patients with preeclampsia who are treated with ARB plus low does Furosemide.

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients who have had a recent pregnancy with preeclampsia

Exclusion criteria

Exclusion criteria: Age under 18 Patients with prior history of hypertension Patients with renal disease Patients with history of congenital heart defects

Design outcomes

Primary

Measure	Time frame
Prevalence of persistent hypertension in day 5 post partum. Timepoint: Day 5 post partum. Method of measurement: Manual sphygmomanometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParisa Hajari

Iran University of Medical Sciences

parisa.hajari72@gmail.com+98 21 6604 4657

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026